Cargando…
Two-pore channels and disease()
Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPC...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Pub. Co
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162333/ https://www.ncbi.nlm.nih.gov/pubmed/29746898 http://dx.doi.org/10.1016/j.bbamcr.2018.05.004 |
_version_ | 1783359122084724736 |
---|---|
author | Patel, Sandip Kilpatrick, Bethan S. |
author_facet | Patel, Sandip Kilpatrick, Bethan S. |
author_sort | Patel, Sandip |
collection | PubMed |
description | Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPCs to disease. We discuss how perturbing both local and global Ca(2+) changes mediated by TPCs through chemical and/or molecular manipulations can induce or reverse disease phenotypes. We cover evidence from models of Parkinson's disease, non-alcoholic fatty liver disease, Ebola infection, cancer, cardiac dysfunction and diabetes. A need for more drugs targeting TPCs is identified. |
format | Online Article Text |
id | pubmed-6162333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Pub. Co |
record_format | MEDLINE/PubMed |
spelling | pubmed-61623332018-11-01 Two-pore channels and disease() Patel, Sandip Kilpatrick, Bethan S. Biochim Biophys Acta Article Two-pore channels (TPCs) are Ca(2+)-permeable endo-lysosomal ion channels subject to multi-modal regulation. They mediate their physiological effects through releasing Ca(2+) from acidic organelles in response to cues such as the second messenger, NAADP. Here, we review emerging evidence linking TPCs to disease. We discuss how perturbing both local and global Ca(2+) changes mediated by TPCs through chemical and/or molecular manipulations can induce or reverse disease phenotypes. We cover evidence from models of Parkinson's disease, non-alcoholic fatty liver disease, Ebola infection, cancer, cardiac dysfunction and diabetes. A need for more drugs targeting TPCs is identified. Elsevier Pub. Co 2018-11 /pmc/articles/PMC6162333/ /pubmed/29746898 http://dx.doi.org/10.1016/j.bbamcr.2018.05.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Patel, Sandip Kilpatrick, Bethan S. Two-pore channels and disease() |
title | Two-pore channels and disease() |
title_full | Two-pore channels and disease() |
title_fullStr | Two-pore channels and disease() |
title_full_unstemmed | Two-pore channels and disease() |
title_short | Two-pore channels and disease() |
title_sort | two-pore channels and disease() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162333/ https://www.ncbi.nlm.nih.gov/pubmed/29746898 http://dx.doi.org/10.1016/j.bbamcr.2018.05.004 |
work_keys_str_mv | AT patelsandip twoporechannelsanddisease AT kilpatrickbethans twoporechannelsanddisease |